Time to go All-In on Celsion?
Celsion (CLSN) is a great story stock. It recently announced their Phase III trial results for liver cancer will be released by the end of January 2013. This will be a top-line release of a multinational, double-blind, placebo-controlled study of primary liver cancer. The results could make or break the company as its future pipeline is dependent on ThermoDox succeeding.
This upcoming catalyst is likely to have a huge impact on the company's valuation. The company has a current market cap of $287 million, but this will likely be drastically different by the end of the month. The CEO of Celsion has stated that this liver cancer treatment will have the potential to generate yearly revenues of $1 billion.
Mastery Bottom Line
Look for a good entry point before betting the farm on CLSN. Shares could dip down to touch the 50 day MA due to some investors not wanting to risk holding through the FDA results. A $7 - $7.50 share price would provide a great buying opportunity.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Goldman Building "Robo-Adviser" For Its 'Poor' Clients (A.K.A. Those With Only $1 Million To Invest) | ZeroHedge
- An OPEC Deal Extension Isn't As Simple As It Sounds | ZeroHedge
- North Korea Blows Up US Aircraft Carrier, Bomber In New Propaganda Video | ZeroHedge
- BofA: This Entire Rally Has Been Institutions Selling To "Animal Spirited" Retail Investors | ZeroHedge
- Judge Orders Google To Hand Over Data On Anyone Who Searched For A Certain Name | ZeroHedge
- Perfect Example Of Why Job Losses From Minimum-Wage-Hikes Are Being Underestimated, 'Bigly' | ZeroHedge
- FHFA Home Price Growth Weakest Since Nov 2013 | ZeroHedge
The most relevant financial news and articles from the Internets
- Former Obama Homeland Security chief says some of Trump's anti-terrorism efforts may be... | Business Insider
- A new kind of doctor's office that charges a monthly fee... | Business Insider
- 'His budget is contrary to African-American interests... | Business Insider
- CHATBOTS EXPLAINED: Why... | Business Insider
- MORGAN STANLEY: We will 'certainly' move people out... | Business Insider
- FedEx slides after earnings miss (FDX, UPS) | Business Insider
- Here's how Uber says it's fixing the 'cult of the individual... | Business Insider